|
ZMYM5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.670250E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.798100E-03 |
| Normal-vs-Stage2 |
3.283000E-01 |
| Normal-vs-Stage3 |
1.160190E-02 |
| Normal-vs-Stage4 |
5.312100E-02 |
| Stage1-vs-Stage2 |
5.295800E-01 |
| Stage1-vs-Stage3 |
6.228000E-01 |
| Stage1-vs-Stage4 |
5.855800E-01 |
| Stage2-vs-Stage3 |
3.832400E-01 |
| Stage2-vs-Stage4 |
4.238200E-01 |
| Stage3-vs-Stage4 |
7.976200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.680160E-02 |
| Normal-vs-AfricanAmerican |
7.668500E-02 |
| Normal-vs-Asian |
1.438790E-01 |
| Caucasian-vs-AfricanAmerican |
9.071600E-01 |
| Caucasian-vs-Asian |
6.108800E-01 |
| AfricanAmerican-vs-Asian |
6.420600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.519400E-03 |
| Normal-vs-Female |
1.347040E-01 |
| Male-vs-Female |
2.905400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.143600E-02 |
| Normal-vs-Extreme_Weight |
5.344100E-03 |
| Normal-vs-Obese |
1.420770E-01 |
| Normal-vs-Extreme_Obese |
2.197400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.707000E-01 |
| Normal_Weight-vs-Obese |
2.968400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.472800E-01 |
| Extreme_Weight-vs-Obese |
1.614830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.695000E-01 |
| Obese-vs-Extreme_Obese |
7.644600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.217690E-02 |
| Normal-vs-Age(41-60Yrs) |
2.437400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.956200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.674370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.418500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.226600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.500400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.200100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.860300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.455800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.266300E-02 |
| Normal-VS-Type2 PRCC |
9.750200E-04 |
| Normal-VS-KIRP CIMP |
2.473900E-02 |
| Normal-VS-Unclassified PRCC |
3.054600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.004700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.620000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.919600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.529800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.212200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.454610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.204300E-04 |
| Normal-vs-N1 |
2.033800E-01 |
| Normal-vs-N2 |
4.04040000012706E-07 |
| N0-vs-N1 |
3.994200E-02 |
| N0-vs-N2 |
1.858500E-03 |
| N1-vs-N2 |
3.178500E-04 |
|
|
